TA-02 – 25 mg

Brand:
Cayman
CAS:
1784751-19-4
Storage:
-20
UN-No:
Non-Hazardous - /

TA-02 is a derivative of the p38 MAPK inhibitor SB 203580 (Item Nos. 13067 | 13344) and an inducer of cardiomyocyte differentiation.{41744} It is cardiomyogenic, increasing expression of the cardiomyocyte marker NKX2-5 by greater than 2-fold and decreasing expression of mesoderm markers and the pre-cardiac marker Isl-1 in HES-3 NKX2-5eGFP/w cells when applied after embryoid body formation at a concentration of 5 μM. TA-02 inhibits casein kinase 1ε (CK1ε) and CK1D and reduces expression of Wnt/β-catenin signaling pathway members, activities that positively correlate with its cardiomyogenic activity.  

 

Available on backorder

SKU: 24668 - 25 mg Category:

Description

An inducer of cardiomyocyte differentiation; increases expression of the cardiomyocyte marker NKX2-5 by >2-fold and decreases expression of mesoderm markers and the pre-cardiac marker Isl-1 in HES-3 NKX2-5eGFP/w cells at 5 μM; inhibits CK1ε and CK1D and reduces expression of Wnt/β-catenin signaling pathway members,


Formal name: 4-[2-(2-fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-pyridine

Synonyms: 

Molecular weight: 333.3

CAS: 1784751-19-4

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Kinase Inhibitors|CK1||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cell Biology|Stem Cell Research|Differentiation